With the help of directed evolution, scientists inch closer to developing viral vectors that can cross the human blood-brain barrier to deliver gene therapy.

The road to developing monoclonal antibodies for effectively targeting cancer was paved with tenacity, passion, and strokes of luck.

Scientists have genetically modified isolated microbes for decades. Now, using CRISPR, they intend to target entire microbiomes.

Microfluidic systems redefined biology by providing platforms that handle small fluid volumes, catalyzing advancements in cellular and molecular studies.

p53 is possibly the most important protein for maintaining cellular function. Losing it is synonymous with cancer.

Scientists transferred light-harvesting proteins into yeast for the first time, shining a light on the past lives of eukaryotic cells.

A 3D variation of pooled CRISPR screens could connect the dots between autism spectrum disorder genetics and cell fate pathways in the developing brain.

Bioengineered bacteria sneak past solid tumor defenses to guide CAR T cells’ attacks.

Recent advances in modeling the human placenta, the least understood organ, may inform placental disorders like preeclampsia.

A combinatorial approach enabled high-throughput screening of protein libraries for desired target binding.